Multiple Immunofluorescence Imaging Analysis Reveals Differential Expression of Disialogangliosides GD3 and GD2 in Neuroblastomas.

Nishimaki, Haruna; Nakanishi, Yoko; Yagasaki, Hiroshi; Masuda, Shinobu

Nishimaki, Haruna; Nakanishi, Yoko; Yagasaki, Hiroshi; Masuda, Shinobu.

Afiliación

Nishimaki H; Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Nakanishi Y; Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Yagasaki H; Department of Pediatric and Child Health, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Masuda S; Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.

Pediatr Dev Pathol ; 25(2): 141-154, 2022.

Article en En | MEDLINE | ID: mdl-34674560

Asunto(s)

Gangliósidos; Neuroblastoma; Niño; Técnica del Anticuerpo Fluorescente; Gangliósidos/metabolismo; Humanos; Inmunohistoquímica; Neuroblastoma/metabolismo

Palabras clave

GD2; GD3; Neuroblastoma; ganglioside; multiple immunofluorescence imaging analysis; risk group

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gangliósidos / Neuroblastoma Límite: Child / Humans Idioma: En Revista: Pediatr Dev Pathol Asunto de la revista: PATOLOGIA / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google